VEGFA and angina pectoris: Data from clinical trials showed that NOGA guided delivery of plasma encoded VEGF in patients with chronic symptomatic angina who are not candidates for conventional means of revascularization effectively improved Canadian Cardiovascular Society (CCS) angina class, while being well tolerated [75].